Market Closed -
Other stock markets
|
Pre-market 06:55:04 | |||
88.11 EUR | +1.49% | 87.76 | -0.39% |
07:44am | US FDA Accepts Sanofi's New Drug Application for Hemophilia Treatment Fitusiran | MT |
06-20 | Cybersecurity firm Semperis raises $125 mln from JP Morgan, Hercules Capital | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.84% | 118B | |
+51.99% | 798B | |
-5.72% | 356B | |
+18.94% | 328B | |
+11.07% | 304B | |
+16.96% | 244B | |
+2.25% | 227B | |
+11.15% | 216B | |
+7.59% | 166B | |
-3.65% | 157B |
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- Sanofi Exercises Option to License 4th NK Cell Engager Program in Solid Tumors From Innate Pharma's ANKET Platform